Influencing Manufacturing Pharmaceutical 
Mad in America
APRIL 2, 2025
Depression was sold to us as a simple problem of serotonin insufficiency, a convenient narrative that made drug companies like Eli Lilly, Forest Pharmaceuticals, and Pfizer very rich. As a former pharmaceutical advertising writer, I not only witnessed the explosive growth in antidepressant drugs, I contributed to it.
Office Snapshots
FEBRUARY 22, 2024
for life science research and manufacturing because it is culturally diverse and is home to a multitude of diverse ways of thinking. The design is influenced by the natural surroundings on which the 56,000 square foot building sits in Marina Del Rey. There is an attraction to L.A.
Mad in America
MARCH 22, 2025
The journal continued to be in good hands, and thus one of the few journals that was receptive to research findings that belied the narrative of therapeutic progress that the psychiatric guild and pharmaceutical companies have been promoting for decades. He noted too the reluctance of the field to consider this possibility.
Mad in America
FEBRUARY 20, 2024
” The study also sheds light on the factors influencing patients’ decisions to continue, switch, or discontinue antidepressant treatment. Stephenson and a team of researchers from various academic and pharmaceutical institutions, including the University of Virginia School of Medicine. The study was authored by Judith J.
Work Life
DECEMBER 15, 2023
Relying solely on a narrow set of approaches can limit the breadth and depth of your influence and hinder the full potential of your organization. In Tony’s work as a leadership coach, he worked with a pharmaceutical CEO who realized that her company’s long-term vision had become blurred.
Mad in America
NOVEMBER 13, 2023
Schatzberg has served as a consultant to or received honoraria from Abbott, Bristol-Myers Squibb, Corcept Therapeutics, Forest Laboratories, Janssen, Eli Lilly, Merck, Mitsubishi Pharmaceuticals, Organon, ParkeDavis, Pfizer, Pharmacia–Upjohn, Sanofi, Scirex, SmithKline Beecham, Solvay, and Wyeth–Ayerst. 10:20 He calls this “scientism”.
Mad in America
OCTOBER 18, 2023
For the pharmaceutical industry, the bigger and wider those diseases, the more people who can be diagnosed, and the bigger your markets are. The marketing of medical conditions has become a key plank of pharmaceutical industry marketing. Helping widen the definitions of disease is a key part of marketing those pharmaceutical products.
Expert insights. Personalized for you.
142 
Let's personalize your content